Crystagen caps #60

$60.70

  • Availability: In Stock

  • 2 or more $56.75
  • 3 or more $54.49

Indications

Viral respiratory infections; strep throat; bronchitis; otitis media; sinusitis.
The course lasts 10-30 days (1-2 packs).

Developed by the St. PETERSBURG Institute of Bioregulation and gerontology on the technology patented by Havinson V. H. Peptide bioregulator of the thymus.

Recommended


- in acute and chronic inflammatory diseases of various etiologies
- with SARS, sore throats, bronchitis, otitis, sinusitis, pneumonia
- cystitis, pyelonephritis, prostatitis, adnexitis
- during preoperative and postoperative periods in various surgical interventions
- in case of generalized infections
- systemic connective tissue diseases
- in the state after extreme stress loads
- with reduced immunity
- to maintain the function of the immune system in the elderly and senile
- for the prevention of cancer
- in case of chronic intoxications
- during rehabilitation after heart attack and stroke
- for rejuvenation of the body as part of complex programs.

Method of application


Adults take 1-2 capsules 1-2 times a day with meals. Duration of administration 10-30 days. It is advisable to repeat the course after 4-6 months.

Contraindications: individual intolerance of components, pregnancy, breast-feeding.

Side effects when using Crystagen not revealed.

Store in a dry, dark place at room temperature.

Composition


Peptide complex as-6-(Proline, glutamic acid, aspartic acid). Excipients: microcrystalline cellulose (E460), beet sugar, lactose, starch, twin-80. As an additional source of peptides.

Contraindications


Individual intolerance of components, pregnancy, breast-feeding. It is recommended to consult a doctor before use.

Bioregulator of normalization of immune system function


Crystagen is a peptide complex that contains amino acids that contribute to the normal function of the immune system.

The clinical study established the effectiveness of Crystagen in the comprehensive prevention and treatment of patients with impaired immune system function after infectious diseases, radiation and chemotherapy, psychoemotional stress, the impact on the body of various adverse factors (including environmental, climatic, geopathogenic factors and ionizing radiation), as well as to maintain the function of the immune system in the elderly and senile age.

It is possible to use Crystagen in order to reduce asthenic syndrome, characteristic of secondary immunodeficiency, normalize the immunological parameters of peripheral blood, improve overall health and reduce the incidence of infectious complications.

Crystagen is recommended to take 1-2 capsules 1-2 times a day with meals. The length of treatment is 20-30 days. It is advisable to repeat the course after 4-6 months.

96 cancer patients after radiation and chemotherapy took part in the clinical study of the effectiveness of the use of Crystagen to optimize the function of the immune system. The main group consisted of 58 patients (32 men, 26 women), who in addition to conventional treatments were prescribed Crystagen 1-2 capsules 2 times a day with meals for 20-30 days, depending on the severity of immune status disorders. 38 patients of the control group received only conventional drugs. The age of patients of both groups ranged from 48 to 70 years. The effectiveness of Crystagen was evaluated by the dynamics of patients ' complaints and a number of objective indicators: General clinical study of blood and urine, immunological study of peripheral blood.

The results of the studies strongly suggest that Crystagen is an effective tool for the correction of secondary immunodeficiency developing in response to extreme factors. The use of Crystagen in combination with symptomatic drugs helped to normalize the disturbed indexes of immune system at 83% of oncological patients after the courses of chemotherapy and radiotherapy.

As follows from the results of immunological research, after the use of Crystagen in cancer patients, almost all indicators were within the physiological norm, there was a significant increase in the content of CD3+ - and CD4+ - lymphocytes, normalization of the ratio of CD4+/CD8+ in peripheral blood. At the same time, patients significantly improved health, disappeared symptoms of intoxication, increased muscle tone and improved appetite. It is noteworthy that all patients of the main group were able to undergo a full course of radiation or chemotherapy (in the control group - 79% of patients).

It should be noted that during the clinical study of the effectiveness of Crystagen side effects, complications and drug dependence were not revealed.